Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients?

Area of Science:

• Critical Care Medicine
• Gastroenterology
• Surgical Outcomes

Background:

• Critically ill patients in surgical ICUs are at high risk for acute erosive gastritis and gastrointestinal (GI) bleeding.
• Prophylactic measures are often employed to mitigate these risks.

Purpose of the Study:

• To evaluate the efficacy of prophylactic antacid treatment in preventing upper GI bleeding in high-risk surgical ICU patients.

Main Methods:

• A randomized controlled trial comparing 65 patients receiving antacid prophylaxis to maintain gastric pH ≥ 5.0 with 61 control patients receiving no prophylaxis.
• Monitoring for microscopic and macroscopic GI bleeding, including severe bleeding events.

Main Results:

• All patients experienced microscopic bleeding, which did not affect outcomes.
• No significant difference in moderate macroscopic bleeding rates between the antacid group (10.8%) and the control group (13.1%).
• One control patient experienced severe GI bleeding; antacid prophylaxis did not prevent macroscopic bleeding.

Conclusions:

• Antacid prophylaxis is not effective in preventing macroscopic upper GI bleeding in high-risk critically ill patients.
• The number of risk factors did not correlate with the rate of upper GI bleeding.
• Routine antacid use is not indicated for preventing GI bleeding in this patient population.